Results 241 to 250 of about 4,854,757 (315)

Destination Therapy with Ventricular Assist Devices

Cardiology, 2004
Despite extensive research and great strides over the past 40 years, the ideal permanent mechanical assist device remains elusive. The incidence of heart failure is increasing, and the number of heart transplants has remained constant. The HeartMate and Novacor are two pulsatile, long-term ventricular assist devices (VADs) commonly used as a bridge to ...
Jai, Raman, Valluvan, Jeevanadam
openaire   +2 more sources

Thermal evaluation of a hermetic transcutaneous energy transfer system to power mechanical circulatory support devices in destination therapy.

Artificial Organs, 2020
BACKGROUND Current generation left ventricular assist devices (LVADs) are powered by a percutaneous driveline. The high prevalence of driveline infections has motivated the development of transcutaneous energy transfer (TET) systems which eliminate ...
Shun Long Cyril Au, D. McCormick, N. Lever, D. Budgett   +3 more
semanticscholar   +1 more source

Adults Living With a Retro-auricular Left Ventricular Assist Device as Destination Therapy: An Interpretive Description.

Journal of Cardiovascular Nursing, 2020
BACKGROUND Increasingly, there is a trend toward the use of left ventricular assist devices (LVADs) for treating advanced heart failure, as both bridge-to-transplant therapy and destination therapy.
M. Luciani, A. Trenta, S. Jack, Massimo Moro, Sara Patella, S. Di Mauro, D. Ausili   +6 more
semanticscholar   +1 more source

Destination Therapy: Current Results and Future Promise

Seminars in Thoracic and Cardiovascular Surgery, 2008
The landmark Randomized Evaluation of Mechanical Assistance in the Treatment of Congestive Heart Failure (REMATCH) trial demonstrated that the implantation of left ventricular assist devices (LVADs) as an alternative to heart transplantation, or destination therapy (DT) is superior to any known medical therapy in patients with end-stage heart failure ...
Katherine, Lietz, Leslie W, Miller
openaire   +2 more sources

What If the Destination Is Transplant? Outcomes of Destination Therapy Patients Who Were Transplanted

ASAIO Journal, 2021
We sought to characterize patients who underwent heart transplant (HTx) following destination therapy (DT) implant in the combined ENDURANCE/ENDURANCE Supplemental Trials (DT/DT2). A post hoc analysis of the DT/DT2 trials was performed. Baseline characteristics and adverse events between the HTx and no-HTx cohorts were analyzed.
Pavan Atluri, Scott C. Silvestry, Jeffrey J. Teuteberg, Carmelo A. Milano, Craig H. Selzman, Jennifer A. Cowger   +5 more
openaire   +2 more sources

Ethics Guidelines for Destination Therapy

The Annals of Thoracic Surgery, 2006
The introduction of the left ventricular assist device as a destination therapy for patients with heart failure introduces several ethical issues. These issues are discussed to help destination therapy teams design ethically sound policies and procedures.
openaire   +2 more sources

Left Ventricular Assist Devices as Destination Therapy

AACN Clinical Issues: Advanced Practice in Acute and Critical Care, 2003
Although an estimated 16,500 Americans annually could benefit from a heart transplant, in 1999 only 2184 heart transplants were performed in the United States. These statistics emphasize the severity of the shortage of available hearts for transplantation.
Virginia Fidrocki, Mason, Annette Jakubisin, Konicki   +1 more
openaire   +2 more sources

Current Technology: Devices Available for Destination Therapy

Cardiology Clinics, 2011
Left ventricular assist device therapy as a destination therapy for end-stage heart failure has made a large leap with continuous flow devices. Continuous flow does not seem to have a detrimental effect on end-organ function, at least in the midterm. Various expected and unexpected complications have been reported associated with this technology.
Hiroo, Takayama, Jonathan A, Yang, Yoshifumi, Naka   +2 more
openaire   +2 more sources

DESTINATION THERAPY WITH DRIVE LESS TOTALARTIFICIAL HEARTS

INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH, 2022
Around 70% of mechanical circulatory devices nd application as bridge to transplantation and 30% as destination devices, but shortage of donor organs forces up to 85% of these to enter the zone of destination devices. There is an urgent need to do away with drive lines as they contribute signicantly to morbidity and mortality with device implantation.
Pradeep Kumar Radhakrishnan, Himabindu A, Gayathri Ananyajyothi Ambat, Sachin Reddy, Sujatha Mohanty, Pulivarthi Nageshwar Rao, Sivakrishna Rao G V, Nagesh Kumar, Bisoi A K, Siva Prasad, Satyanarayana Murthy, Satyanarayana M R S, Ravishankar Ravishankar, Srinivas Srinivas, Valluvan Jeevanandam, Venugopal P   +15 more
openaire   +1 more source

Destination therapy: time for real progress

Nature Clinical Practice Cardiovascular Medicine, 2008
Both prognosis and quality of life are poor for severely symptomatic patients with stage D heart failure, and treatment options are limited. Few individuals are eligible for cardiac transplantation, and ventricular resynchronization therapy provides only marginal benefit in select patients.
openaire   +2 more sources